Growing Demand for Bioburden Testing With Growth in the Medical Devices, Pharmaceutical, and Biotechnology Industries
What This Report Will Provide? This study involved four major activities in estimating the current size of the bioburden testing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments. Expected Revenue Growth: [129 Pages Report] MarketsandMarkets forecasts the bioburden testing market to grow from USD 1.10 billion by 2023 from USD 0.61 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 12.4% Major Growth Boosters: The market is witnessing growth due to factors such as growth in the medical devices, pharmaceutical, and biotechnology in...